Skip to main content

Table 4 Prognostic factors for OS by Cox proportional hazards regression model

From: Combination of the gamma-glutamyltransferase-to-prealbumin ratio and other indicators may be a novel marker for predicting the prognosis of patients with hepatocellular carcinoma undergoing locoregional ablative therapies

Factors

Univariate

 

Multivariate

 

HR (95% CI)

P

HR (95% CI)

P

Gender

2.76 (0.84–9.07)

0.094

  

Age

0.91 (0.44–1.87)

0.810

  

Diabetes mellitus

1.49 (0.69–3.23)

0.307

  

High blood pressure

1.51 (0.72–3.14)

0.269

  

History of smoking

1.85 (0.92–3.73)

0.082

  

History of drinking

1.25 (0.61–2.55)

0.541

  

Cirrhosis

2.30 (0.80–6.56)

0.119

  

Child-Pugh class

2.38 (1.18–4.78)

0.014

0.81 (0.29–2.21)

0.685

Antiviral therapy

0.67 (0.33–1.36)

0.273

  

Tumor number

3.77 (1.87–7.60)

< 0.0001

3.05 (1.32–7.02)

0.009

Tumor size

2.24 (1.12–4.05)

0.022

2.05 (0.90–4.66)

0.084

Ablation method

1.36 (0.90–2.04)

0.137

  

etiology

1.59 (0.97–2.60)

0.063

  

AFP

1.65 (0.99–2.72)

0.050

1.03 (0.57–1.85)

0.914

viral load

1.22 (0.54–2.75)

0.624

  

ALT(U/L)

1.00 (0.98–1.01)

0.773

  

AST(U/L)

1.03 (1.00–1.05)

0.007

1.02 (0.99–1.05)

0.121

Total serum bilirubin (mg/dL)

1.03 (1.00–1.06)

0.040

1.02 (0.98–1.07)

0.262

Neutrophil count (10^9/L)

0.77 (0.60–0.99)

0.045

0.65 (0.47–0.91)

0.014

Lymphocyte count (10^9/L)

0.82 (0.43–1.57)

0.565

  

Platelet count (10^9/L)

1.00 (0.99–1.01)

0.797

  

Albumin

0.88 (0.81–0.95)

0.002

0.96 (0.86–1.06)

0.441

Globulin

1.05 (1.00–1.11)

0.023

0.99 (0.93–1.05)

0.841

Fibrinogen (mg/dL)

1.00 (0.69–1.46)

0.980

  

GPR

1.34 (1.14–1.58)

< 0.0001

1.34 (1.00–1.81)

0.047

  1. Abbreviations: AFP alpha-fetoprotein, ALT alanine aminotransferase, AST aspartate aminotransferase, GPR gamma-glutamyltransferase to prealbumin ratio, the GPR was estimated as the gamma-glutamyltransferase divided by the prealbumin